<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pulmonic regurgitation</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pulmonic regurgitation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pulmonic regurgitation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alexander C Egbe, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Heidi M Connolly, MD, FACC, FASE</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William A Zoghbi, MD, FASE, FAHA, MACC</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 14, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H21100652"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Physiologic trace to mild pulmonic valve regurgitation (also known as pulmonic regurgitation or PR) commonly occurs in normal individuals. Greater degrees of PR are caused by various disorders and can lead to right ventricular (RV) volume overload and right heart failure.</p><p>The causes, clinical manifestations, diagnosis, and treatment of PR are discussed here. Echocardiography of the pulmonic valve is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5290.html" rel="external">"Echocardiographic evaluation of the pulmonic valve and pulmonary artery"</a>.)</p><p class="headingAnchor" id="H21100658"><span class="h1">CAUSES AND ASSOCIATED CONDITIONS</span><span class="headingEndMark"> — </span>The etiologies of PR can be classified into physiologic, primary, and secondary causes. Primary causes include iatrogenic, infectious (infective endocarditis), immune-mediated (rheumatic heart disease), systemic (carcinoid disease), and congenital [<a href="#rid1">1-3</a>].<strong> </strong>The epidemiology of primary PR is unknown, but it occurs in up to 30 percent of patients with certain congenital heart conditions such as after operation or intervention for tetralogy of Fallot and valvular pulmonic stenosis [<a href="#rid4">4,5</a>]. Secondary or functional PR occurs in patients with a morphologically normal pulmonic valve who have pulmonary artery dilatation and/or severe pulmonary arterial hypertension [<a href="#rid6">6,7</a>]. (See  <a class="medical medical_review" href="/z/d/html/8249.html" rel="external">"Clinical features and diagnosis of pulmonary hypertension of unclear etiology in adults"</a> and  <a class="medical medical_review" href="/z/d/html/121912.html" rel="external">"Treatment and prognosis of pulmonary arterial hypertension in adults (group 1)"</a>.)</p><p>Physiologic trivial or mild PR is a common finding on color Doppler echocardiography of normal hearts [<a href="#rid8">8-10</a>].</p><p>The most common cause of severe PR is iatrogenic, due to surgical valvotomy/valvectomy or balloon pulmonary valvuloplasty performed for RV outflow tract obstruction as a component of Tetralogy of Fallot (or other conotruncal abnormality) repair [<a href="#rid11">11-14</a>] or for congenital pulmonic valve stenosis. Other causes of severe PR include endocarditis and carcinoid. (See  <a class="medical medical_review" href="/z/d/html/5769.html" rel="external">"Tetralogy of Fallot (TOF): Pathophysiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5770.html" rel="external">"Tetralogy of Fallot (TOF): Management and outcome"</a> and  <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/2614.html" rel="external">"Clinical features of carcinoid syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/8120.html" rel="external">"Clinical manifestations and diagnosis of pulmonic stenosis in adults"</a>.)</p><p>Congenital PR is rare and does not usually occur in isolation. It is seen in patients with tetralogy of Fallot and absent pulmonary valve syndrome, and in this setting, it usually presents as a mixed stenotic and regurgitant lesion [<a href="#rid15">15,16</a>].</p><p class="headingAnchor" id="H21100664"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>PR leads to RV volume overload, with subsequent RV enlargement, RV dysfunction, and functional tricuspid valve regurgitation. Chamber enlargement also gives rise to atrial and ventricular arrhythmias, and risk of morbidity and mortality if untreated [<a href="#rid17">17-21</a>].</p><p>PR is initially well tolerated, and patients are usually asymptomatic for many years [<a href="#rid22">22</a>]. However, with time, the RV dilates to compensate for the excess volume load in an effort to maintain cardiac output [<a href="#rid23">23</a>]. Progressive RV dilation eventually leads to RV dysfunction [<a href="#rid21">21,24,25</a>]. With further deterioration in RV function, cardiac output starts to decrease, and increased heart rate and oxygen extraction are required to maintain adequate tissue oxygenation. At that point, any increase in oxygen demand such as exercise is poorly tolerated [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H21100670"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H654787453"><span class="h2">Symptoms and signs</span><span class="headingEndMark"> — </span>Patients with PR are usually asymptomatic prior to onset of RV dysfunction.</p><p>In patients with severe PR developing RV dysfunction, initial symptoms consist of exertional dyspnea and fatigue owing to inability of the RV to increase its output in response to physical exertion [<a href="#rid23">23</a>]. With progression of RV dysfunction, and the onset of atrial and ventricular arrhythmias, patients may present with lightheadedness, palpitations, and rarely syncope. With enlargement of the RV and dilatation of the tricuspid valve annulus, tricuspid regurgitation may develop and when significant, can cause hepatic congestion, ascites, and pedal edema [<a href="#rid22">22</a>]. Chest pain is uncommon in patients with isolated severe PR.</p><p>Cardiac examination findings vary with the severity and cause of PR. The murmur of PR begins in early diastole and is generally best heard over the left second and third interspaces. The murmur may increase in intensity with inspiration.</p><p>In individuals with physiologic PR, cardiac exam findings are normal. An early diastolic murmur may be detected in thin individuals with mild PR. (See  <a class="medical medical_review" href="/z/d/html/1078.html" rel="external">"Auscultation of cardiac murmurs in adults", section on 'Pulmonic regurgitation'</a>.)</p><p>In patients with more significant PR, there may be a systolic ejection murmur at the left upper sternal border due to increased RV stroke volume. A third heart sound may be present but a fourth heart sound is unusual. In patients with severe PR a mildly accentuated RV impulse is generally present; however, the jugular venous pressure is usually normal. A prominent jugular venous "a" wave may be present in the setting of pulmonary artery hypertension, and a prominent "v" wave is noted in patients with severe tricuspid valve regurgitation. (See  <a class="medical medical_review" href="/z/d/html/1078.html" rel="external">"Auscultation of cardiac murmurs in adults"</a> and  <a class="medical medical_review" href="/z/d/html/1079.html" rel="external">"Auscultation of heart sounds"</a> and  <a class="medical medical_review" href="/z/d/html/1076.html" rel="external">"Examination of the jugular venous pulse"</a>.)</p><p>The murmur of PR associated with pulmonary hypertension (Graham-Steell murmur) is high pitched and "blowing." It begins with an accentuated P2 component of the second heart sound. The duration of the murmur is variable and may occupy all of diastole if there is a pandiastolic gradient between the pulmonary artery and the RV diastolic pressure. The murmur has a decrescendo configuration and it may increase in intensity with inspiration. (See  <a class="medical medical_review" href="/z/d/html/1078.html" rel="external">"Auscultation of cardiac murmurs in adults", section on 'Pulmonic regurgitation'</a>.)</p><p>The murmur of PR differs in patients without pulmonary hypertension, such as most patients with PR after tetralogy of Fallot repair or other conditions requiring pulmonic valvotomy, idiopathic dilatation of the pulmonary artery, right-sided endocarditis, or congenital absence of the pulmonic valve. In these conditions, the pulmonary artery diastolic pressure is normal or low and there is a lower rate of regurgitant flow; the regurgitant murmur is of low to medium pitch and may be brief, in early diastole, because of early equalization of pulmonary artery and RV diastolic pressures. A to-and-fro murmur over the left second intercostal space may be noted or there may be no audible murmur with severe pulmonic regurgitation. In patients with normal pulmonary pressures, the murmur of PR may be inaudible.</p><p>In congenital absence of the pulmonic valve, P2 is absent and there is a silent interval between A2 and the onset of the regurgitant murmur. A loud to-and-fro murmur may be heard in these patients.</p><p class="headingAnchor" id="H654787474"><span class="h2">Test findings</span></p><p class="headingAnchor" id="H654787503"><span class="h3">Electrocardiogram</span><span class="headingEndMark"> — </span>An electrocardiogram (ECG) is not required for the diagnosis of PR but is commonly obtained to identify associated conditions such as arrhythmias and findings suggestive of RV hypertrophy and congenital heart disease. The ECG usually demonstrates sinus rhythm, although arrhythmias may develop, as described above. Right bundle branch block with QRS prolongation is common in patients with repaired tetralogy of Fallot and longstanding severe PR  (<a class="graphic graphic_diagnosticimage graphicRef105325" href="/z/d/graphic/105325.html" rel="external">image 1</a>). Right axis deviation and criteria for RV hypertrophy may be present in patients with associated RV outflow tract obstruction or pulmonary arterial hypertension [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H654787523"><span class="h3">Chest radiograph</span><span class="headingEndMark"> — </span>A chest radiograph is not required for the diagnosis of PR but is commonly obtained in patients with dyspnea as an aid in evaluating pulmonary and cardiac causes. The most distinctive radiographic feature in patients with severe PR is RV enlargement. This is appreciated from a lateral chest radiograph as reduced retrosternal airspace. In addition, on the posteroanterior image, the left heart border demonstrates superior displacement of the apex. The main pulmonary trunk may be prominent but pulmonary vascularity is usually normal. The right atrium will be enlarged in patients with associated tricuspid regurgitation  (<a class="graphic graphic_diagnosticimage graphicRef105327" href="/z/d/graphic/105327.html" rel="external">image 2</a>). Patients with prior operation will demonstrate features of prior sternotomy/thoracotomy and/or valve prosthesis.</p><p class="headingAnchor" id="H21100676"><span class="h1">DIAGNOSIS AND EVALUATION</span></p><p class="headingAnchor" id="H714143446"><span class="h2">Approach to diagnosis and evaluation</span><span class="headingEndMark"> — </span>The diagnosis of pulmonic regurgitation (PR) should be considered in patients with an early diastolic murmur, in patients with incidentally detected RV enlargement, as well as in patients with a history of surgical valvotomy/valvectomy or balloon pulmonary valvuloplasty performed for RV outflow tract obstruction. Patients with repaired tetralogy of Fallot also frequently demonstrate severe PR due to patch enlargement of the RV outflow tract.</p><p>All patients with suspected valve disease should be evaluated by an echocardiogram, which generally confirms the diagnosis and also provides an evaluation of the mechanism, cause, and severity of valve disease, its hemodynamic effects, and assessment of associated disorders (such as pulmonary artery hypertension or tricuspid valve regurgitation).</p><p>Patients with moderate or greater PR should also undergo evaluation by cardiovascular magnetic resonance (CMR) imaging if available, which enables quantitative assessment of PR and of RV size and function, which may impact timing of intervention. Computed tomography (CT) is not generally required for the diagnosis and evaluation of PR but may be helpful in patients with suboptimal echocardiographic views who are not eligible for CMR testing.</p><p>Exercise testing is not generally required but may be helpful in patients with exertional symptoms that are greater than expected for the observed degree of valve disease and RV dysfunction. Cardiac catheterization is not generally required but is helpful in selected patients in the evaluation of pulmonary arterial hypertension. (See  <a class="medical medical_review" href="/z/d/html/8249.html" rel="external">"Clinical features and diagnosis of pulmonary hypertension of unclear etiology in adults"</a> and  <a class="medical medical_review" href="/z/d/html/121912.html" rel="external">"Treatment and prognosis of pulmonary arterial hypertension in adults (group 1)"</a>.)</p><p class="headingAnchor" id="H21100696"><span class="h2">Echocardiogram</span><span class="headingEndMark"> — </span>Two-dimensional and Doppler echocardiography are the most useful diagnostic tools in patients with PR. Echocardiography delineates the mechanism of regurgitation such as flail or dysplastic cusps, restricted cusp mobility (as seen in carcinoid heart disease), or pulmonary valve malcoaptation as seen in functional PR secondary to pulmonary arterial hypertension or idiopathic pulmonary artery dilatation [<a href="#rid6">6,7,9,10</a>]. In patients with infective endocarditis affecting the pulmonic valve, vegetations may be difficult to detect on transthoracic and transesophageal echocardiography; these imaging modalities are complementary [<a href="#rid27">27</a>]. (See  <a class="medical medical_review" href="/z/d/html/5290.html" rel="external">"Echocardiographic evaluation of the pulmonic valve and pulmonary artery", section on 'Clinical considerations'</a>.)</p><p>Parasternal short and long axis windows are the preferred views for assessing pulmonary valve anatomy and Doppler hemodynamics [<a href="#rid28">28</a>]. Apical and subcostal views can complement pulmonary valve anatomic and hemodynamic assessment. Color and spectral Doppler echocardiography are useful in quantifying the degree of PR [<a href="#rid28">28,29</a>].</p><p>PR severity is determined by jet width and duration  (<a class="graphic graphic_table graphicRef104840" href="/z/d/graphic/104840.html" rel="external">table 1</a>). With mild PR, there is a thin regurgitant jet width. With moderate PR, the regurgitant jet widens but remains &lt;50 percent of the pulmonary valve annulus width. With severe PR, the color jet fills the RV outflow tract (&gt;50 percent of the pulmonary valve annulus dimension). PR is typically a holodiastolic jet; however, in severe PR, equalization of pulmonary artery and RV pressures occurs early- to mid-diastole, causing cessation of the jet. Severe PR is often underappreciated by color flow Doppler echocardiography due to the laminar signal and jet termination in early diastole  (<a class="graphic graphic_diagnosticimage graphicRef105329 graphicRef105331" href="/z/d/graphic/105329.html" rel="external">image 3A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/5290.html" rel="external">"Echocardiographic evaluation of the pulmonic valve and pulmonary artery", section on 'Pulmonic valve regurgitation'</a>.)</p><p>Vena contracta width, pulsed-wave Doppler flow measurement in the pulmonary arteries, and assessment of the continuous wave Doppler signal density and contour are important ancillary echocardiographic parameters used in the assessment of PR severity  (<a class="graphic graphic_table graphicRef104840" href="/z/d/graphic/104840.html" rel="external">table 1</a>) [<a href="#rid3">3,30</a>]. With mild PR, the continuous wave Doppler signal density is light and the deceleration rate is slow. With moderate PR, the continuous wave Doppler signal density is moderate and the deceleration rate is variable. With severe PR, there is dense continuous wave Doppler signal, steep deceleration, and early termination of diastolic flow.</p><p>RV enlargement, systolic dysfunction, sequelae of severe PR can also be qualitatively assessed using two-dimensional Doppler echocardiography.</p><p>Due to the anterior location of the pulmonary valve, transesophageal echocardiography rarely provides incremental information about the severity of PR not detected on the transthoracic echocardiogram. Three-dimensional echocardiography has been reported to be useful in the assessment of PR in select patients [<a href="#rid31">31,32</a>]. (See  <a class="medical medical_review" href="/z/d/html/5290.html" rel="external">"Echocardiographic evaluation of the pulmonic valve and pulmonary artery", section on 'Pulmonic valve regurgitation'</a>.)</p><p>A comprehensive echocardiographic assessment should also include determination of left ventricular (LV) function, which is a prognostic factor for long-term survival [<a href="#rid33">33-36</a>], and associated anomalies such as tricuspid regurgitation, branch pulmonary artery stenosis, and intracardiac shunt.</p><p class="headingAnchor" id="H21100702"><span class="h2">Cardiovascular magnetic resonance</span><span class="headingEndMark"> — </span>CMR imaging is the preferred modality for the assessment of RV enlargement and dysfunction, important sequelae of long-standing severe PR [<a href="#rid19">19,29,37,38</a>]. We suggest CMR in patients with moderate or greater PR. CMR can also be used for quantitative assessment of the severity of PR, including calculation of the regurgitant volume. The absence of ionizing radiation makes it ideal for serial assessment of disease progression  (<a class="graphic graphic_diagnosticimage graphicRef105332" href="/z/d/graphic/105332.html" rel="external">image 4</a>). Exogenous contrast is not needed to quantify the severity of PR or assess RV size and function.</p><p class="headingAnchor" id="H714143143"><span class="h2">Computed tomography</span><span class="headingEndMark"> — </span>CT can be used to evaluate the impact of PR on right heart size and function but is generally not used for serial assessment unless there is a contraindication to CMR such as an implanted cardiac pacemaker/device that is not MR compatible. Concerns about serial CT imaging include the use of ionizing radiation and iodinated contrast agent. In select cases, CT may be helpful prior to intervention to help determine whether percutaneous intervention is an option or before reoperation for surgical planning and assessment for coronary anatomy and atherosclerosis.</p><p class="headingAnchor" id="H21100708"><span class="h2">Exercise testing</span><span class="headingEndMark"> — </span>Cardiopulmonary exercise testing provides prognostic information and may also be useful in deciding the timing of pulmonary valve replacement in patients with exertional symptoms out of proportion to disease severity and the degree of RV dysfunction [<a href="#rid23">23,39</a>]. Exercise testing is also useful in screening for exercise-induced arrhythmias and may be useful in risk stratification for sudden death [<a href="#rid40">40</a>].</p><p class="headingAnchor" id="H21100714"><span class="h2">Cardiac catheterization</span><span class="headingEndMark"> — </span>Assessment of the mechanism, severity, and hemodynamic burden of PR can generally be reliably accomplished using non-invasive modalities. Cardiac catheterization, therefore, has a limited role in the diagnostic evaluation of patients with PR. It is primarily used in the evaluation of pulmonary vascular resistance in patients with pulmonary arterial hypertension, preoperative coronary artery assessment, or as part of comprehensive assessment for the patients being considered for percutaneous pulmonary valve replacement. Occasionally, preoperative invasive hemodynamic assessment helps to risk stratify patients with PR and associated lesions such as constrictive pericarditis, severe tricuspid regurgitation, and RV diastolic dysfunction. Cardiac catheterization may be helpful in differentiating the primary lesion. The hemodynamic findings of severe PR include low pulmonary artery end-diastolic pressure, resulting in wide pulse pressure; increased RV end-diastolic pressure; and in some cases, the pulmonary artery pressure tracing may become similar to the RV pressure tracing ("ventricularization") [<a href="#rid41">41</a>]. As compared with aortic root angiogram for assessment of aortic regurgitation, pulmonary artery angiogram is rarely performed in the current era.</p><p class="headingAnchor" id="H654787576"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>An echocardiogram is used to distinguish pulmonic regurgitation (PR) from other causes of diastolic murmurs and right heart failure described here.</p><p>The differential diagnosis of a murmur consistent with PR includes other causes of diastolic murmurs, particularly aortic regurgitation (AR), which is associated with a similar decrescendo diastolic murmur starting in early diastole. The PR murmur can be distinguished from the murmur of AR by its increase in intensity during inspiration and its location (PR is best heard over the left second and third interspaces; AR is heard over left sternal border or over the right second interspace). A left anterior descending coronary artery stenosis is a rare cause of a diastolic murmur similar to that of PR. Mid- or late-diastolic murmurs caused by conditions such as mitral or tricuspid stenosis are less likely to be confused with the murmur of PR given differences in their timing, quality, and associated sounds. (See  <a class="medical medical_review" href="/z/d/html/1078.html" rel="external">"Auscultation of cardiac murmurs in adults", section on 'Early diastolic murmurs'</a>.)</p><p>The differential diagnoses of severe RV enlargement and dysfunction includes tricuspid regurgitation, left-to-right shunt resulting in RV volume overload, primary right heart myopathy such as arrhythmogenic RV cardiomyopathy, and the late phase of pulmonary hypertension.</p><p>In a patient with PR and symptoms of heart failure, a thorough cardiovascular evaluation (including history, physical examination, and echocardiography) is required to determine the cause of symptoms. Symptomatic right heart failure in a patient with PR with preserved RV function should prompt investigation for alternative diagnosis such as constrictive pericarditis and restrictive physiology. (See  <a class="medical medical_review" href="/z/d/html/4938.html" rel="external">"Constrictive pericarditis: Diagnostic evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/4946.html" rel="external">"Differentiating constrictive pericarditis and restrictive cardiomyopathy"</a> and  <a class="medical medical_review" href="/z/d/html/4918.html" rel="external">"Restrictive cardiomyopathies"</a> and  <a class="medical medical_review" href="/z/d/html/5330.html" rel="external">"Echocardiographic recognition of cardiomyopathies"</a>.)</p><p class="headingAnchor" id="H654787556"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H654787563"><span class="h2">Monitoring</span><span class="headingEndMark"> — </span>Patients with moderate or severe PR should be followed annually for clinical change by history, physical examination, and echocardiography. Earlier assessment is indicated if symptoms develop to determine optimal time for pulmonary valve replacement. CMR imaging should also be performed periodically.</p><p>Adults with repaired tetralogy of Fallot should generally have at least annual follow-up with a cardiologist with expertise in adult congenital heart disease, as recommended in the 2018 American College of Cardiology/American Heart Association (ACC/AHA) adult congenital heart disease guidelines [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/5770.html" rel="external">"Tetralogy of Fallot (TOF): Management and outcome"</a>.)</p><p>Patients who have undergone surgical or percutaneous balloon pulmonary valvotomy should receive long-term follow-up by clinical examination and echocardiography to assess the severity of PR, RV size and function, tricuspid regurgitation, and pulmonary artery pressures [<a href="#rid3">3</a>]. The frequency of follow-up should vary according to the severity of disease, but should be at least every five years.</p><p class="headingAnchor" id="H21100720"><span class="h2">Medical therapy</span><span class="headingEndMark"> — </span>Patients with asymptomatic, severe PR and normal RV function do not require any medical therapy.</p><p>For the patients with secondary PR, medical therapy should be directed at the underlying cause such as pulmonary arterial hypertension or carcinoid disease. (See  <a class="medical medical_review" href="/z/d/html/8250.html" rel="external">"Treatment of pulmonary arterial hypertension (group 1) in adults: Pulmonary hypertension-specific therapy"</a> and  <a class="medical medical_review" href="/z/d/html/8135.html" rel="external">"Carcinoid heart disease"</a>.)</p><p>In patients with right heart failure and severe RV dysfunction who are not candidates for surgical or percutaneous intervention, medical therapy with diuretics, angiotensin converting enzyme inhibitors, and <a class="drug drug_general" data-topicid="9360" href="/z/d/drug information/9360.html" rel="external">digoxin</a> may be used but have not been demonstrated to provide survival benefit.</p><p>Endocarditis prophylaxis is not indicated for native PR unless there is a history of prior endocarditis. (See  <a class="medical medical_review" href="/z/d/html/2147.html" rel="external">"Prevention of endocarditis: Antibiotic prophylaxis and other measures"</a>.)</p><p class="headingAnchor" id="H21100726"><span class="h2">Intervention</span></p><p class="headingAnchor" id="H21102292"><span class="h3">Surgical</span></p><p class="headingAnchor" id="H732618537"><span class="h4">Indications</span><span class="headingEndMark"> — </span>Surgical pulmonary valve replacement or, in select situations, percutaneous pulmonary valve replacement is indicated in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span>For symptomatic, severe PR, surgical pulmonic valve replacement is recommended [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For asymptomatic, severe PR when any two of the following four criteria are present, surgical pulmonic valve replacement is suggested [<a href="#rid42">42-44</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mild or moderate RV or LV systolic dysfunction.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severe RV dilation (RV end-diastolic volume index [RVEDVI] ≥160 mL/m<sup>2</sup>, or RV end-systolic volume index [RVESVI] ≥80 mL/m<sup>2</sup>, or RVEDV greater than or equal to two times the LV end-diastolic volume).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>RV systolic pressure due to RV outflow tract obstruction greater than or equal to two-thirds the systemic pressure.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Progressive reduction in objective exercise tolerance.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We also suggest pulmonary valve replacement for patients with asymptomatic severe PR and progressive tricuspid valve regurgitation, although evidence is more limited to support this approach. (See  <a class="medical medical_review" href="/z/d/html/141526.html" rel="external">"Tetralogy of Fallot (TOF): Long-term complications and follow-up after repair", section on 'Pulmonary valve replacement (PVR)'</a>.)</p><p></p><p>Simultaneous tricuspid annuloplasty is recommended in patients with moderate or worse tricuspid valve regurgitation due to tricuspid annular dilatation, while tricuspid valve replacement should be considered in cases of structurally abnormal valve due to damage from prior endocarditis or iatrogenic injury resulting in flail leaflet or leaflet perforation.</p><p>The first two indications above are similar to recommendations in the 2018 ACC/AHA adult congenital heart disease guidelines [<a href="#rid3">3</a>].</p><p>Indications for surgery for PR are based upon limited observational data, largely in patients with severe PR and repaired tetralogy of Fallot [<a href="#rid45">45</a>]. As described below, untreated severe PR is associated with right heart failure, and surgical treatment is associated with low risk and improved outcomes. The goal of pulmonary valve replacement is to eliminate volume overload of the RV and prevent irreversible ventricular dysfunction [<a href="#rid46">46</a>]. (See <a class="local">'Outcomes'</a> below.)</p><p class="headingAnchor" id="H732618578"><span class="h4">Valve choice</span><span class="headingEndMark"> — </span>In patients undergoing surgical pulmonic valve replacement, bioprosthetic valves are generally preferred over mechanical valve prostheses with longevity up to approximately 15 years after implantation [<a href="#rid37">37,47,48</a>]. For patients that are at high risk for reoperation or already have a mechanical valve prosthesis in place (and thus already require anticoagulation), mechanical valve prosthesis may be appropriate [<a href="#rid49">49,50</a>].</p><p class="headingAnchor" id="H21100733"><span class="h3">Percutaneous</span><span class="headingEndMark"> — </span>Patients with native PR are occasionally candidates for percutaneous pulmonary valve replacement [<a href="#rid51">51-56</a>]. The configuration of the native RV outflow tract is highly variable and depends on the type of initial intervention; thus, there is an increased risk of perivalvular regurgitation and device embolization. Although percutaneous pulmonic valve implantation has been performed in some cases of native PR, limited data are available to support this approach.</p><p>By contrast, percutaneous replacement of the pulmonary valve is an option for patients with prosthetic pulmonic valve regurgitation, including those with a pulmonary artery conduit with regurgitant prosthetic valve [<a href="#rid57">57-60</a>]. This procedure is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/86481.html" rel="external">"Transcatheter pulmonary valve implantation"</a>.)</p><p class="headingAnchor" id="H654787613"><span class="h3">Follow-up after valve replacement</span><span class="headingEndMark"> — </span>Following pulmonary valve replacement, all patients require an initial transthoracic echocardiogram to assess baseline valve hemodynamics for future comparison.</p><p>Meticulous anticoagulation management is required for all patients with mechanical valve prosthesis [<a href="#rid47">47,49,61</a>].</p><p>We now recommend temporary oral anticoagulation for three to six months after pulmonary valve replacement with a bioprosthesis, given our experience with bioprosthetic valve thrombosis [<a href="#rid62">62</a>]. For patients with bioprosthetic pulmonic valves, we suggest daily <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> for the lifespan of the prosthesis. Long-term oral anticoagulation is indicated in patients with bioprosthetic pulmonic valves only when there are other indications for anticoagulation such as atrial arrhythmia, prior thromboembolic event, or features of premature prosthesis dysfunction concerning for bioprosthetic valve thrombosis [<a href="#rid63">63,64</a>].</p><p>All patients with a prosthetic pulmonic valve need life-long follow-up to assess valve and ventricular function [<a href="#rid65">65,66</a>]. In our practice, we check bioprosthetic valve function by echocardiographic imaging early postoperatively ("fingerprint") and then again within the first 12 to 18 months after implantation to monitor for development of changes related to bioprosthetic valve thrombosis. Unless an abnormality is found, further routine annual echocardiography generally is not required until 10 years after isolated-pulmonary valve implantation unless there is a change in clinical presentation. Given the high risk of infective endocarditis with a prosthetic heart valve, antimicrobial prophylaxis for bacterial endocarditis is recommended according to standard guidelines. (See  <a class="medical medical_review" href="/z/d/html/2147.html" rel="external">"Prevention of endocarditis: Antibiotic prophylaxis and other measures"</a>.)</p><p class="headingAnchor" id="H21100739"><span class="h1">OUTCOMES</span><span class="headingEndMark"> — </span>Untreated severe pulmonic valve regurgitation will result in RV enlargement, systolic dysfunction, arrhythmia, and death [<a href="#rid17">17-21,46</a>]. Surgical pulmonic valve replacement is a well-established treatment strategy with &lt;1 percent periprocedural mortality, when performed by an experienced surgeon, and excellent long-term outcome with &gt;60 percent freedom from reoperation at 10 years [<a href="#rid37">37,47</a>]. The timing of intervention is a crucial factor for long-term patient morbidity and survival. The freedom from reintervention after percutaneous pulmonary valve replacement is &gt;90 percent at one year, but long-term data are lacking [<a href="#rid58">58-60,67</a>]. Cardiovascular magnetic resonance-derived preoperative RV volume and function are prognostic; preoperative RV end-diastolic volume index &lt;160 mL/m<sup>2</sup> and end-systolic volume index &lt;80 mL/m<sup>2</sup> are associated with normalization of ventricular dimensions during the first postoperative year [<a href="#rid37">37,42,68-72</a>].</p><p>Similarly, preoperative RV end-systolic volume index &lt;80 mL/m<sup>2</sup> was strongly associated with mid-to-late (mean 6.3 years; interquartile range 4.9 to 9.5 years) RV normalization (ejection fraction &gt;48 percent and RV end-diastolic volume &lt;108 mL/m<sup>2</sup>) [<a href="#rid73">73</a>]. Conversely, a RV end-systolic volume &gt;95 mL/m<sup>2</sup> was associated with increased risk for suboptimal hemodynamic outcome and adverse clinical events.</p><p>Structural valve failure and infective endocarditis are significant long-term complications after pulmonary valve replacement that require meticulous follow-up [<a href="#rid37">37,47,58,74-77</a>].</p><p class="headingAnchor" id="H3885897117"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/115482.html" rel="external">"Society guideline links: Cardiac valve disease"</a>.)</p><p class="headingAnchor" id="H21100751"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Severe pulmonic regurgitation (PR) is most commonly iatrogenic, due to surgical or percutaneous procedures to treat right ventricular (RV) outflow obstruction. Other causes of severe PR include endocarditis and carcinoid heart disease. (See <a class="local">'Causes and associated conditions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe PR leads to RV volume overload, with subsequent RV enlargement, RV dysfunction, and functional tricuspid valve regurgitation. Chamber enlargement also gives rise to atrial and ventricular arrhythmias and risk of morbidity and mortality if untreated. (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with severe PR are usually asymptomatic prior to onset of RV dysfunction. In patients with severe PR developing RV dysfunction, initial symptoms consist of exertional dyspnea and fatigue owing to inability of the RV to increase its output in response to physical exertion. (See <a class="local">'Symptoms and signs'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac examination findings vary with the severity and cause of PR. The murmur of PR begins in early diastole and is generally best heard over the left second and third interspaces. The murmur may increase in intensity with inspiration. (See <a class="local">'Symptoms and signs'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of PR is generally confirmed by echocardiography, which also provides an evaluation of the mechanism, cause, and severity of valve disease, its hemodynamic effects, and assessment of associated disorders (such as pulmonary artery hypertension). (See <a class="local">'Approach to diagnosis and evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with moderate or severe PR should be followed annually for clinical change by history, physical examination, echocardiography, and cardiovascular magnetic resonance (CMR) imaging (if available). Earlier assessment is indicated if symptoms develop, to determine optimal time for pulmonary valve replacement. (See <a class="local">'Monitoring'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The following are indications for surgical valve replacement for PR or, in select situations, percutaneous pulmonary valve replacement (see <a class="local">'Indications'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We recommend pulmonary valve replacement for symptomatic, severe PR.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We suggest pulmonary valve replacement for asymptomatic, severe PR when any two of the following criteria are present:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Mild or moderate RV or left ventricular (LV) systolic dysfunction.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Severe RV dilation (RV end-diastolic volume index [RVEDVI] ≥160 mL/m<sup>2</sup>, or RV end-systolic volume index [RVESVI] ≥80 mL/m<sup>2</sup>, or RVEDV greater than or equal to two times the LV end-diastolic volume).</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>RV systolic pressure due to RV outflow tract obstruction greater than or equal to two-thirds the systemic pressure.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Progressive reduction in objective exercise tolerance.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We suggest pulmonary valve replacement for patients with severe PR and progressive tricuspid valve regurgitation, although evidence is more limited to support this approach.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Untreated severe PR will result in RV enlargement, systolic dysfunction, arrhythmia, and death. Surgical pulmonary valve replacement is a well-established treatment strategy with &lt;1 percent periprocedural mortality when performed by an experienced surgeon and excellent long-term outcome with &gt;60 percent freedom from reoperation at 10 years. (See <a class="local">'Outcomes'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hamza N, Ortiz J, Bonomo RA. Isolated pulmonic valve infective endocarditis: a persistent challenge. Infection 2004; 32:170.</a></li><li><a class="nounderline abstract_t">Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 1993; 87:1188.</a></li><li><a class="nounderline abstract_t">Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 139:e637.</a></li><li><a class="nounderline abstract_t">Egbe AC, Miranda WR, Said SM, et al. Risk stratification and clinical outcomes after surgical pulmonary valve replacement. Am Heart J 2018; 206:105.</a></li><li><a class="nounderline abstract_t">El-Harasis MA, Connolly HM, Miranda WR, et al. Progressive right ventricular enlargement due to pulmonary regurgitation: Clinical characteristics of a "low-risk" group. Am Heart J 2018; 201:136.</a></li><li><a class="nounderline abstract_t">Ristow B, Ahmed S, Wang L, et al. Pulmonary regurgitation end-diastolic gradient is a Doppler marker of cardiac status: data from the Heart and Soul Study. J Am Soc Echocardiogr 2005; 18:885.</a></li><li><a class="nounderline abstract_t">Renella P, Aboulhosn J, Lohan DG, et al. Two-dimensional and Doppler echocardiography reliably predict severe pulmonary regurgitation as quantified by cardiac magnetic resonance. J Am Soc Echocardiogr 2010; 23:880.</a></li><li><a class="nounderline abstract_t">Ansari A. Isolated pulmonary valvular regurgitation: current perspectives. Prog Cardiovasc Dis 1991; 33:329.</a></li><li><a class="nounderline abstract_t">Yoshida K, Yoshikawa J, Shakudo M, et al. Color Doppler evaluation of valvular regurgitation in normal subjects. Circulation 1988; 78:840.</a></li><li><a class="nounderline abstract_t">Maciel BC, Simpson IA, Valdes-Cruz LM, et al. Color flow Doppler mapping studies of "physiologic" pulmonary and tricuspid regurgitation: evidence for true regurgitation as opposed to a valve closing volume. J Am Soc Echocardiogr 1991; 4:589.</a></li><li><a class="nounderline abstract_t">Hayes CJ, Gersony WM, Driscoll DJ, et al. Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis. Circulation 1993; 87:I28.</a></li><li><a class="nounderline abstract_t">McCrindle BW, Kan JS. Long-term results after balloon pulmonary valvuloplasty. Circulation 1991; 83:1915.</a></li><li><a class="nounderline abstract_t">O'Connor BK, Beekman RH, Lindauer A, Rocchini A. Intermediate-term outcome after pulmonary balloon valvuloplasty: comparison with a matched surgical control group. J Am Coll Cardiol 1992; 20:169.</a></li><li><a class="nounderline abstract_t">Rebergen SA, Chin JG, Ottenkamp J, et al. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation 1993; 88:2257.</a></li><li><a class="nounderline abstract_t">MILLER RA, LEV M, PAUL MH. Congenital absence of the pulmonary valve. The clinical syndrome of tetralogy of Fallot with pulmonary regurgitation. Circulation 1962; 26:266.</a></li><li><a class="nounderline abstract_t">Zucker N, Rozin I, Levitas A, Zalzstein E. Clinical presentation, natural history, and outcome of patients with the absent pulmonary valve syndrome. Cardiol Young 2004; 14:402.</a></li><li><a class="nounderline abstract_t">Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 1993; 329:593.</a></li><li><a class="nounderline abstract_t">Nollert G, Fischlein T, Bouterwek S, et al. Long-term results of total repair of tetralogy of Fallot in adulthood: 35 years follow-up in 104 patients corrected at the age of 18 or older. Thorac Cardiovasc Surg 1997; 45:178.</a></li><li><a class="nounderline abstract_t">Geva T, Sandweiss BM, Gauvreau K, et al. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol 2004; 43:1068.</a></li><li><a class="nounderline abstract_t">Khairy P, Aboulhosn J, Gurvitz MZ, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation 2010; 122:868.</a></li><li><a class="nounderline abstract_t">Frigiola A, Redington AN, Cullen S, Vogel M. Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot. Circulation 2004; 110:II153.</a></li><li><a class="nounderline abstract_t">Shimazaki Y, Blackstone EH, Kirklin JW. The natural history of isolated congenital pulmonary valve incompetence: surgical implications. Thorac Cardiovasc Surg 1984; 32:257.</a></li><li><a class="nounderline abstract_t">Frigiola A, Giardini A, Taylor A, et al. Echocardiographic assessment of diastolic biventricular properties in patients operated for severe pulmonary regurgitation and association with exercise capacity. Eur Heart J Cardiovasc Imaging 2012; 13:697.</a></li><li><a class="nounderline abstract_t">Schwartz MC, Rome JJ, Gillespie MJ, et al. Relation of left ventricular end diastolic pressure to right ventricular end diastolic volume after operative treatment of tetralogy of fallot. Am J Cardiol 2012; 109:417.</a></li><li><a class="nounderline abstract_t">Knauth AL, Gauvreau K, Powell AJ, et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart 2008; 94:211.</a></li><li><a class="nounderline abstract_t">Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation 1995; 92:231.</a></li><li><a class="nounderline abstract_t">Miranda WR, Connolly HM, DeSimone DC, et al. Infective Endocarditis Involving the Pulmonary Valve. Am J Cardiol 2015; 116:1928.</a></li><li><a class="nounderline abstract_t">Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23:685.</a></li><li><a class="nounderline abstract_t">Li W, Davlouros PA, Kilner PJ, et al. Doppler-echocardiographic assessment of pulmonary regurgitation in adults with repaired tetralogy of Fallot: comparison with cardiovascular magnetic resonance imaging. Am Heart J 2004; 147:165.</a></li><li><a class="nounderline abstract_t">Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017; 30:303.</a></li><li><a class="nounderline abstract_t">Vogel M, Gutberlet M, Dittrich S, et al. Comparison of transthoracic three dimensional echocardiography with magnetic resonance imaging in the assessment of right ventricular volume and mass. Heart 1997; 78:127.</a></li><li><a class="nounderline abstract_t">Shimada YJ, Shiota M, Siegel RJ, Shiota T. Accuracy of right ventricular volumes and function determined by three-dimensional echocardiography in comparison with magnetic resonance imaging: a meta-analysis study. J Am Soc Echocardiogr 2010; 23:943.</a></li><li><a class="nounderline abstract_t">Ghai A, Silversides C, Harris L, et al. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol 2002; 40:1675.</a></li><li><a class="nounderline abstract_t">Abd El Rahman MY, Hui W, Yigitbasi M, et al. Detection of left ventricular asynchrony in patients with right bundle branch block after repair of tetralogy of Fallot using tissue-Doppler imaging-derived strain. J Am Coll Cardiol 2005; 45:915.</a></li><li><a class="nounderline abstract_t">Kondo C, Nakazawa M, Kusakabe K, Momma K. Left ventricular dysfunction on exercise long-term after total repair of tetralogy of Fallot. Circulation 1995; 92:II250.</a></li><li><a class="nounderline abstract_t">Hausdorf G, Hinrichs C, Nienaber CA, et al. Left ventricular contractile state after surgical correction of tetralogy of Fallot: risk factors for late left ventricular dysfunction. Pediatr Cardiol 1990; 11:61.</a></li><li><a class="nounderline abstract_t">Lee C, Kim YM, Lee CH, et al. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol 2012; 60:1005.</a></li><li><a class="nounderline abstract_t">Holmes KW. Timing of pulmonary valve replacement in tetralogy of fallot using cardiac magnetic resonance imaging: an evolving process. J Am Coll Cardiol 2012; 60:1015.</a></li><li><a class="nounderline abstract_t">Babu-Narayan SV, Diller GP, Gheta RR, et al. Clinical outcomes of surgical pulmonary valve replacement after repair of tetralogy of Fallot and potential prognostic value of preoperative cardiopulmonary exercise testing. Circulation 2014; 129:18.</a></li><li><a class="nounderline abstract_t">Fukushige J, Shimomura K, Harada T, et al. Exercise-induced ventricular arrhythmia after repair of tetralogy of Fallot. Acta Paediatr Jpn 1989; 31:30.</a></li><li><a class="nounderline abstract_t">Rommel JJ, Yadav PK, Stouffer GA. Causes and hemodynamic findings in chronic severe pulmonary regurgitation. Catheter Cardiovasc Interv 2015.</a></li><li><a class="nounderline abstract_t">Hooft van Huysduynen B, Henkens IR, Swenne CA, et al. Pulmonary valve replacement in tetralogy of Fallot improves the repolarization. Int J Cardiol 2008; 124:301.</a></li><li><a class="nounderline abstract_t">Stephenson EA, Redington AN. Reduction of QRS duration following pulmonary valve replacement in tetralogy of Fallot: implications for arrhythmia reduction? Eur Heart J 2005; 26:863.</a></li><li><a class="nounderline abstract_t">Therrien J, Siu SC, Harris L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001; 103:2489.</a></li><li><a class="nounderline abstract_t">Egbe AC, Vallabhajosyula S, Connolly HM. Trends and outcomes of pulmonary valve replacement in tetralogy of Fallot. Int J Cardiol 2020; 299:136.</a></li><li><a class="nounderline abstract_t">Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson 2011; 13:9.</a></li><li><a class="nounderline abstract_t">Jang W, Kim YJ, Choi K, et al. Mid-term results of bioprosthetic pulmonary valve replacement in pulmonary regurgitation after tetralogy of Fallot repair. Eur J Cardiothorac Surg 2012; 42:e1.</a></li><li><a class="nounderline abstract_t">Egbe AC, Miranda WR, Ammash NM, et al. Use of mechanical valve prostheses in adults with tetralogy of Fallot. Int J Cardiol 2019; 291:45.</a></li><li><a class="nounderline abstract_t">Stulak JM, Dearani JA, Burkhart HM, et al. The increasing use of mechanical pulmonary valve replacement over a 40-year period. Ann Thorac Surg 2010; 90:2009.</a></li><li><a class="nounderline abstract_t">Stulak JM, Mora BN, Said SM, et al. Mechanical Pulmonary Valve Replacement. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2016; 19:82.</a></li><li><a class="nounderline abstract_t">Cools B, Brown SC, Heying R, et al. Percutaneous pulmonary valve implantation for free pulmonary regurgitation following conduit-free surgery of the right ventricular outflow tract. Int J Cardiol 2015; 186:129.</a></li><li><a class="nounderline abstract_t">Guccione P, Milanesi O, Hijazi ZM, Pongiglione G. Transcatheter pulmonary valve implantation in native pulmonary outflow tract using the Edwards SAPIEN™ transcatheter heart valve. Eur J Cardiothorac Surg 2012; 41:1192.</a></li><li><a class="nounderline abstract_t">Suntharos P, Prieto LR. Percutaneous Pulmonary Valve Implantation in the Native Right Ventricular Outflow Tract Using a 29-mm Edwards SAPIEN 3 Valve. World J Pediatr Congenit Heart Surg 2016.</a></li><li><a class="nounderline abstract_t">Poterucha JT, Foley TA, Taggart NW. Percutaneous pulmonary valve implantation in a native outflow tract: 3-dimensional DynaCT rotational angiographic reconstruction and 3-dimensional printed model. JACC Cardiovasc Interv 2014; 7:e151.</a></li><li><a class="nounderline abstract_t">Bergersen L, Benson LN, Gillespie MJ, et al. Harmony Feasibility Trial: Acute and Short-Term Outcomes With a Self-Expanding Transcatheter Pulmonary Valve. JACC Cardiovasc Interv 2017; 10:1763.</a></li><li><a class="nounderline abstract_t">Schoonbeek RC, Takebayashi S, Aoki C, et al. Implantation of the Medtronic Harmony Transcatheter Pulmonary Valve Improves Right Ventricular Size and Function in an Ovine Model of Postoperative Chronic Pulmonary Insufficiency. Circ Cardiovasc Interv 2016; 9.</a></li><li><a class="nounderline abstract_t">Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial. J Am Coll Cardiol 2009; 54:1722.</a></li><li><a class="nounderline abstract_t">McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010; 122:507.</a></li><li><a class="nounderline abstract_t">Eicken A, Ewert P, Hager A, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J 2011; 32:1260.</a></li><li><a class="nounderline abstract_t">Kenny D, Hijazi ZM, Kar S, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol 2011; 58:2248.</a></li><li><a class="nounderline abstract_t">Sabate Rotes A, Bonnichsen CR, Reece CL, et al. Long-term follow-up in repaired tetralogy of fallot: can deformation imaging help identify optimal timing of pulmonary valve replacement? J Am Soc Echocardiogr 2014; 27:1305.</a></li><li><a class="nounderline abstract_t">Egbe AC, Pislaru SV, Pellikka PA, et al. Bioprosthetic Valve Thrombosis Versus Structural Failure: Clinical and Echocardiographic Predictors. J Am Coll Cardiol 2015; 66:2285.</a></li><li><a class="nounderline abstract_t">Pislaru SV, Hussain I, Pellikka PA, et al. Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: lessons from a case series. Eur J Cardiothorac Surg 2015; 47:725.</a></li><li><a class="nounderline abstract_t">Egbe AC, Connolly HM, Pellikka PA, et al. Outcomes of Warfarin Therapy for Bioprosthetic Valve Thrombosis of Surgically Implanted Valves: A Prospective Study. JACC Cardiovasc Interv 2017; 10:379.</a></li><li><a class="nounderline abstract_t">Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52:e143.</a></li><li><a class="nounderline abstract_t">Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31:2915.</a></li><li><a class="nounderline abstract_t">Jones TK, Rome JJ, Armstrong AK, et al. Transcatheter Pulmonary Valve Replacement Reduces Tricuspid Regurgitation in Patients With Right Ventricular Volume/Pressure Overload. J Am Coll Cardiol 2016; 68:1525.</a></li><li><a class="nounderline abstract_t">Oosterhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007; 116:545.</a></li><li><a class="nounderline abstract_t">Therrien J, Provost Y, Merchant N, et al. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005; 95:779.</a></li><li><a class="nounderline abstract_t">Buechel ER, Dave HH, Kellenberger CJ, et al. Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance. Eur Heart J 2005; 26:2721.</a></li><li><a class="nounderline abstract_t">Ferraz Cavalcanti PE, Sá MP, Santos CA, et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. J Am Coll Cardiol 2013; 62:2227.</a></li><li><a class="nounderline abstract_t">Geva T, Gauvreau K, Powell AJ, et al. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation 2010; 122:S201.</a></li><li><a class="nounderline abstract_t">Bokma JP, Winter MM, Oosterhof T, et al. Preoperative thresholds for mid-to-late haemodynamic and clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Eur Heart J 2016; 37:829.</a></li><li><a class="nounderline abstract_t">McElhinney DB, Benson LN, Eicken A, et al. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv 2013; 6:292.</a></li><li><a class="nounderline abstract_t">Cheung G, Vejlstrup N, Ihlemann N, et al. Infective endocarditis following percutaneous pulmonary valve replacement: diagnostic challenges and application of intra-cardiac echocardiography. Int J Cardiol 2013; 169:425.</a></li><li><a class="nounderline abstract_t">Hascoet S, Mauri L, Claude C, et al. Infective Endocarditis Risk After Percutaneous Pulmonary Valve Implantation With the Melody and Sapien Valves. JACC Cardiovasc Interv 2017; 10:510.</a></li><li><a class="nounderline abstract_t">Miranda WR, Connolly HM, Bonnichsen CR, et al. Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults. Eur Heart J Cardiovasc Imaging 2016; 17:936.</a></li></ol></div><div id="topicVersionRevision">Topic 104752 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15188078" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Isolated pulmonic valve infective endocarditis: a persistent challenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7681733" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30586768" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30343246" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Risk stratification and clinical outcomes after surgical pulmonary valve replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29793063" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Progressive right ventricular enlargement due to pulmonary regurgitation: Clinical characteristics of a "low-risk" group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16153508" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Pulmonary regurgitation end-diastolic gradient is a Doppler marker of cardiac status: data from the Heart and Soul Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20591618" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Two-dimensional and Doppler echocardiography reliably predict severe pulmonary regurgitation as quantified by cardiac magnetic resonance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2003147" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Isolated pulmonary valvular regurgitation: current perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3262454" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Color Doppler evaluation of valvular regurgitation in normal subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1760180" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Color flow Doppler mapping studies of "physiologic" pulmonary and tricuspid regurgitation: evidence for true regurgitation as opposed to a valve closing volume.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8425320" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2040044" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Long-term results after balloon pulmonary valvuloplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1607519" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Intermediate-term outcome after pulmonary balloon valvuloplasty: comparison with a matched surgical control group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8222120" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14474089" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Congenital absence of the pulmonary valve. The clinical syndrome of tetralogy of Fallot with pulmonary regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15680047" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Clinical presentation, natural history, and outcome of patients with the absent pulmonary valve syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7688102" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9323819" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Long-term results of total repair of tetralogy of Fallot in adulthood: 35 years follow-up in 104 patients corrected at the age of 18 or older.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15028368" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20713900" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15364855" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6207619" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The natural history of isolated congenital pulmonary valve incompetence: surgical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22315361" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Echocardiographic assessment of diastolic biventricular properties in patients operated for severe pulmonary regurgitation and association with exercise capacity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22078963" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Relation of left ventricular end diastolic pressure to right ventricular end diastolic volume after operative treatment of tetralogy of fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17135219" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7600655" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26611123" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Infective Endocarditis Involving the Pulmonary Valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20620859" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14691436" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Doppler-echocardiographic assessment of pulmonary regurgitation in adults with repaired tetralogy of Fallot: comparison with cardiovascular magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28314623" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9326984" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Comparison of transthoracic three dimensional echocardiography with magnetic resonance imaging in the assessment of right ventricular volume and mass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20797527" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Accuracy of right ventricular volumes and function determined by three-dimensional echocardiography in comparison with magnetic resonance imaging: a meta-analysis study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12427422" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15766829" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Detection of left ventricular asynchrony in patients with right bundle branch block after repair of tetralogy of Fallot using tissue-Doppler imaging-derived strain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7586419" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Left ventricular dysfunction on exercise long-term after total repair of tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2349143" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Left ventricular contractile state after surgical correction of tetralogy of Fallot: risk factors for late left ventricular dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22921969" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22921970" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Timing of pulmonary valve replacement in tetralogy of fallot using cardiac magnetic resonance imaging: an evolving process.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24146254" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Clinical outcomes of surgical pulmonary valve replacement after repair of tetralogy of Fallot and potential prognostic value of preoperative cardiopulmonary exercise testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2504024" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Exercise-induced ventricular arrhythmia after repair of tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26104675" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Causes and hemodynamic findings in chronic severe pulmonary regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17433464" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Pulmonary valve replacement in tetralogy of Fallot improves the repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15802362" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Reduction of QRS duration following pulmonary valve replacement in tetralogy of Fallot: implications for arrhythmia reduction?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11369690" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31351788" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Trends and outcomes of pulmonary valve replacement in tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21251297" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22561653" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Mid-term results of bioprosthetic pulmonary valve replacement in pulmonary regurgitation after tetralogy of Fallot repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30803889" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Use of mechanical valve prostheses in adults with tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21095354" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The increasing use of mechanical pulmonary valve replacement over a 40-year period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27060049" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Mechanical Pulmonary Valve Replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25818755" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Percutaneous pulmonary valve implantation for free pulmonary regurgitation following conduit-free surgery of the right ventricular outflow tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22228842" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Transcatheter pulmonary valve implantation in native pulmonary outflow tract using the Edwards SAPIEN™transcatheter heart valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27864470" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Percutaneous Pulmonary Valve Implantation in the Native Right Ventricular Outflow Tract Using a 29-mm Edwards SAPIEN 3 Valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25341717" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Percutaneous pulmonary valve implantation in a native outflow tract: 3-dimensional DynaCT rotational angiographic reconstruction and 3-dimensional printed model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28882284" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Harmony Feasibility Trial: Acute and Short-Term Outcomes With a Self-Expanding Transcatheter Pulmonary Valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27662847" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Implantation of the Medtronic Harmony Transcatheter Pulmonary Valve Improves Right Ventricular Size and Function in an Ovine Model of Postoperative Chronic Pulmonary Insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19850214" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20644013" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21273201" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22078433" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25441332" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Long-term follow-up in repaired tetralogy of fallot: can deformation imaging help identify optimal timing of pulmonary valve replacement?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26610876" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Bioprosthetic Valve Thrombosis Versus Structural Failure: Clinical and Echocardiographic Predictors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24829402" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: lessons from a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28231905" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Outcomes of Warfarin Therapy for Bioprosthetic Valve Thrombosis of Surgically Implanted Valves: A Prospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19038677" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20801927" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27687194" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Transcatheter Pulmonary Valve Replacement Reduces Tricuspid Regurgitation in Patients With Right Ventricular Volume/Pressure Overload.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17620511" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15757612" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16214832" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24080109" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20837914" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26508165" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Preoperative thresholds for mid-to-late haemodynamic and clinical outcomes after pulmonary valve replacement in tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23735475" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24182680" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Infective endocarditis following percutaneous pulmonary valve replacement: diagnostic challenges and application of intra-cardiac echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28279319" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Infective Endocarditis Risk After Percutaneous Pulmonary Valve Implantation With the Melody and Sapien Valves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27161836" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
